Jiangxi University of Traditional Chinese Medicine, 1088 Meilingdadao Road, Nanchang, 330004, China.
AAPS PharmSciTech. 2017 Oct;18(7):2744-2753. doi: 10.1208/s12249-017-0756-7. Epub 2017 Mar 24.
The objective of this study is to prepare a novel drug nanosuspension modified by a natural triterpenoid saponin (glycyrrhizin (GZ)) and evaluate its stability and redispersibility. A poorly soluble drug (andrographolide (AGE)) was used as a model drug. AGE nanosuspensions (AGE-NS) using GZ as natural stabilizer with mean particle size of 487 nm were firstly prepared by homogenization and converted into dried AGE nanosuspension powder (AGE-NP) by freeze-drying. It was found that GZ was able to prevent the aggregation of AGE nanocrystals and the freeze-dried AGE-NP could easily redisperse back to AGE-NS. It was related with special properties of GZ that possessed the interfacial property (37.02 ± 0.29 N/m) and electrostatic effect (-43.6 ± 0.9 mV) and could entrap AGE nanocrystals into its network structure. The freeze-dried AGE-NP/GZ exhibited excellent performance, compared with those combined with trehalose as matrix formers. The powder X-ray diffraction result demonstrated that GZ did not alter the AGE crystal state. The dissolution of AGE-NP/GZ (99.87%) was significantly enhanced, compared with the coarse AGE (42.35%). This study demonstrated that GZ could be used as a novel multifunctional stabilizer for production of drug nanosuspensions and provided a promising basis for further formulation development of poorly soluble drug.
本研究的目的是制备一种新型药物纳米混悬剂,该纳米混悬剂经过一种天然三萜皂苷(甘草酸(GZ))修饰,并对其稳定性和再分散性进行评价。以难溶性药物(穿心莲内酯(AGE))作为模型药物。首先使用 GZ 作为天然稳定剂,通过均质法制备平均粒径为 487nm 的 AGE 纳米混悬剂(AGE-NS),并通过冷冻干燥将其转化为干燥的 AGE 纳米混悬剂粉末(AGE-NP)。结果表明,GZ 能够防止 AGE 纳米晶体的聚集,并且冻干的 AGE-NP 可以很容易地重新分散回 AGE-NS。这与 GZ 具有界面性质(37.02±0.29N/m)和静电效应(-43.6±0.9mV)并能将 AGE 纳米晶体包裹在其网络结构中的特殊性质有关。与使用海藻糖作为基质形成剂结合的 AGE-NP 相比,冻干的 AGE-NP/GZ 表现出优异的性能。粉末 X 射线衍射结果表明,GZ 没有改变 AGE 的晶体状态。与粗 AGE(42.35%)相比,AGE-NP/GZ 的溶解度(99.87%)显著提高。本研究表明,GZ 可用作生产药物纳米混悬剂的新型多功能稳定剂,并为进一步开发难溶性药物的制剂提供了有前景的基础。